RadioMedix, Inc.
RadioMedix, Inc., headquartered in the United States, is a pioneering force in the radiopharmaceutical industry, specialising in the development and commercialisation of innovative diagnostic and therapeutic solutions. Founded in 2011, the company has made significant strides in advancing targeted radiotherapy, particularly in oncology, with a focus on improving patient outcomes. With a robust portfolio of unique products, including radiolabelled agents for imaging and treatment, RadioMedix stands out for its commitment to precision medicine. The company operates primarily in North America, with expanding influence in global markets. Recognised for its cutting-edge research and development, RadioMedix has established a strong market position, contributing to the evolution of personalised cancer care through its state-of-the-art technologies.
DitchCarbon Score
How does RadioMedix, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
RadioMedix, Inc.'s score of 23 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
RadioMedix, Inc.'s reported carbon emissions
RadioMedix, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or other industry standards. As there are no emissions data or reduction initiatives available, it is unclear how RadioMedix, Inc. is addressing its carbon footprint or contributing to climate action within its industry. The lack of information suggests that the company may still be in the early stages of developing its climate strategy or reporting framework.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
RadioMedix, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
